Dr. Fisher is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Nebraska Medical Ctr
Omaha, NE 68198Phone+1 402-559-7620
Education & Training
- Indiana University School of MedicineResidency, Pathology-Anatomic and Clinical, 2013 - 2016
- University of Nebraska College of MedicineClass of 2013, MD/PhD
Certifications & Licensure
- NE State Medical License 2015 - 2026
- IA State Medical License 2017 - 2025
- American Board of Pathology Anatomic Pathology
- American Board of Pathology Pathology - Anatomic
Publications & Presentations
PubMed
- KSR1 mediates small-cell lung carcinoma tumor initiation and cisplatin resistance.Deepan Chatterjee, Robert A Svoboda, Dianna H Huisman, Benjamin J Drapkin, Heidi M Vieira
Molecular Cancer Research. 2025-02-10 - 4 citationsNuclear phosphoinositide signaling promotes YAP/TAZ-TEAD transcriptional activity in breast cancer.Oisun Jung, Min-Jeong Baek, Colin Wooldrik, Keith R Johnson, Kurt W Fisher
The EMBO Journal. 2024-05-01 - 2 citationsAlbendazole inhibits colon cancer progression and therapy resistance by targeting ubiquitin ligase RNF20.Iram Fatima, Rizwan Ahmad, Susmita Barman, Saiprasad Gowrikumar, Kristina Pravoverov
British Journal of Cancer. 2024-04-01
Press Mentions
- Medical Research Highlights, August 2024August 9th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: